COVID-19 Outbreak-Global Neuroscience Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
- Report Code : MAI1957734
- Published On: Aug, 2020
- Category : Healthcare & Pharma
- Pages : 130
-
The Neuroscience market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.
Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.
In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Neuroscience industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.
The Neuroscience market can be split based on product types, major applications, and important countries as follows:
Key players in the global Neuroscience market covered in Chapter 12:
Lupin Ltd.
Astrazeneca Plc
Sun Pharmaceutical Industries Ltd. (Sun Pharma)
Biogen
UCB SA
Alembic Pharmaceuticals Ltd.
Torrent Pharmaceuticals Ltd.
Sanofi
Abbvie
Dr. Reddy'S Laboratories Ltd.
F. Hoffmann-La Roche Ag
Daiichi Sankyo Co., Ltd.
Avanir Pharmaceuticals Inc.
Autism Therapeutics
Merck & Co
H. Lundbeck A/S
Eli Lilly And Co.
Alexza Pharmaceuticals
United Therapeutics Corp.
Allergan Plc
Novartis Ag
Teva Pharmaceutical Industries Ltd.
Alkermes Plc
Boehringer Ingelheim
Pfizer Inc.
Johnson & Johnson
Eisai Co. Ltd.
Aurobindo Pharma
Sumitomo Dainippon Pharma Co., Ltd.
Otsuka Holdings Co., Ltd.
Acadia Pharmaceuticals, Inc.
Gedeon Richter Plc
Lannett Co., Inc.
Apotex, Inc.
Glaxosmithkline Plc
Mallinckrodt
Immunocellular Therapeutics, Ltd.
Nextsource Biotechnology Llc
Mylan Nv
Bristol-Myers Squibb Co.
In Chapter 4 and 14.1, on the basis of types, the Neuroscience market from 2015 to 2025 is primarily split into:
Anti-Parkinson's Drugs
Alzheimer Disease
Psychotic Disorders
Epileptic Disorders
Autism Spectrum Disorders
Others
In Chapter 5 and 14.2, on the basis of applications, the Neuroscience market from 2015 to 2025 covers:
Hospitals
Diagnostic Laboratories
Research Institutes
Other
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
-
With tables and figures helping analyze worldwide COVID 19 Outbreak Global Neuroscience market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Table of Content
1 Neuroscience Introduction and Market Overview1.1 Objectives of the Study
1.2 Overview of Neuroscience
1.3 Scope of The Study
1.3.1 Key Market Segments
1.3.2 Players Covered
1.3.3 COVID-19's impact on the Neuroscience industry1.4 Methodology of The Study
1.5 Research Data Source
2 Executive Summary2.1 Market Overview
2.1.1 Global Neuroscience Market Size, 2015 – 2020
2.1.2 Global Neuroscience Market Size by Type, 2015 – 2020
2.1.3 Global Neuroscience Market Size by Application, 2015 – 2020
2.1.4 Global Neuroscience Market Size by Region, 2015 - 20252.2 Business Environment Analysis
2.2.1 Global COVID-19 Status and Economic Overview
2.2.2 Influence of COVID-19 Outbreak on Neuroscience Industry Development
3 Industry Chain Analysis3.1 Upstream Raw Material Suppliers of Neuroscience Analysis
3.2 Major Players of Neuroscience
3.3 Neuroscience Manufacturing Cost Structure Analysis
3.3.1 Production Process Analysis
3.3.2 Manufacturing Cost Structure of Neuroscience
3.3.3 Labor Cost of Neuroscience3.4 Market Distributors of Neuroscience
3.5 Major Downstream Buyers of Neuroscience Analysis
3.6 The Impact of Covid-19 From the Perspective of Industry Chain
3.7 Regional Import and Export Controls Will Exist for a Long Time
3.8 Continued downward PMI Spreads Globally
4 Global Neuroscience Market, by Type4.1 Global Neuroscience Value and Market Share by Type (2015-2020)
4.2 Global Neuroscience Production and Market Share by Type (2015-2020)
4.3 Global Neuroscience Value and Growth Rate by Type (2015-2020)
4.3.1 Global Neuroscience Value and Growth Rate of Anti-Parkinson's Drugs
4.3.2 Global Neuroscience Value and Growth Rate of Alzheimer Disease
4.3.3 Global Neuroscience Value and Growth Rate of Psychotic Disorders
4.3.4 Global Neuroscience Value and Growth Rate of Epileptic Disorders
4.3.5 Global Neuroscience Value and Growth Rate of Autism Spectrum Disorders
4.3.6 Global Neuroscience Value and Growth Rate of Others4.4 Global Neuroscience Price Analysis by Type (2015-2020)
5 Neuroscience Market, by Application5.1 Downstream Market Overview
5.2 Global Neuroscience Consumption and Market Share by Application (2015-2020)
5.3 Global Neuroscience Consumption and Growth Rate by Application (2015-2020)
5.3.1 Global Neuroscience Consumption and Growth Rate of Hospitals (2015-2020)
5.3.2 Global Neuroscience Consumption and Growth Rate of Diagnostic Laboratories (2015-2020)
5.3.3 Global Neuroscience Consumption and Growth Rate of Research Institutes (2015-2020)
5.3.4 Global Neuroscience Consumption and Growth Rate of Other (2015-2020)
6 Global Neuroscience Market Analysis by Regions6.1 Global Neuroscience Sales, Revenue and Market Share by Regions
6.1.1 Global Neuroscience Sales by Regions (2015-2020)
6.1.2 Global Neuroscience Revenue by Regions (2015-2020)6.2 North America Neuroscience Sales and Growth Rate (2015-2020)
6.3 Europe Neuroscience Sales and Growth Rate (2015-2020)
6.4 Asia-Pacific Neuroscience Sales and Growth Rate (2015-2020)
6.5 Middle East and Africa Neuroscience Sales and Growth Rate (2015-2020)
6.6 South America Neuroscience Sales and Growth Rate (2015-2020)
7 North America Neuroscience Market Analysis by Countries7.1 The Influence of COVID-19 on North America Market
7.2 North America Neuroscience Sales, Revenue and Market Share by Countries
7.2.1 North America Neuroscience Sales by Countries (2015-2020)
7.2.2 North America Neuroscience Revenue by Countries (2015-2020)7.3 United States Neuroscience Sales and Growth Rate (2015-2020)
7.4 Canada Neuroscience Sales and Growth Rate (2015-2020)
7.5 Mexico Neuroscience Sales and Growth Rate (2015-2020)
8 Europe Neuroscience Market Analysis by Countries8.1 The Influence of COVID-19 on Europe Market
8.2 Europe Neuroscience Sales, Revenue and Market Share by Countries
8.2.1 Europe Neuroscience Sales by Countries (2015-2020)
8.2.2 Europe Neuroscience Revenue by Countries (2015-2020)8.3 Germany Neuroscience Sales and Growth Rate (2015-2020)
8.4 UK Neuroscience Sales and Growth Rate (2015-2020)
8.5 France Neuroscience Sales and Growth Rate (2015-2020)
8.6 Italy Neuroscience Sales and Growth Rate (2015-2020)
8.7 Spain Neuroscience Sales and Growth Rate (2015-2020)
8.8 Russia Neuroscience Sales and Growth Rate (2015-2020)
9 Asia Pacific Neuroscience Market Analysis by Countries9.1 The Influence of COVID-19 on Asia Pacific Market
9.2 Asia Pacific Neuroscience Sales, Revenue and Market Share by Countries
9.2.1 Asia Pacific Neuroscience Sales by Countries (2015-2020)
9.2.2 Asia Pacific Neuroscience Revenue by Countries (2015-2020)9.3 China Neuroscience Sales and Growth Rate (2015-2020)
9.4 Japan Neuroscience Sales and Growth Rate (2015-2020)
9.5 South Korea Neuroscience Sales and Growth Rate (2015-2020)
9.6 India Neuroscience Sales and Growth Rate (2015-2020)
9.7 Southeast Asia Neuroscience Sales and Growth Rate (2015-2020)
9.8 Australia Neuroscience Sales and Growth Rate (2015-2020)
10 Middle East and Africa Neuroscience Market Analysis by Countries10.1 The Influence of COVID-19 on Middle East and Africa Market
10.2 Middle East and Africa Neuroscience Sales, Revenue and Market Share by Countries
10.2.1 Middle East and Africa Neuroscience Sales by Countries (2015-2020)
10.2.2 Middle East and Africa Neuroscience Revenue by Countries (2015-2020)10.3 Saudi Arabia Neuroscience Sales and Growth Rate (2015-2020)
10.4 UAE Neuroscience Sales and Growth Rate (2015-2020)
10.5 Egypt Neuroscience Sales and Growth Rate (2015-2020)
10.6 Nigeria Neuroscience Sales and Growth Rate (2015-2020)
10.7 South Africa Neuroscience Sales and Growth Rate (2015-2020)
11 South America Neuroscience Market Analysis by Countries11.1 The Influence of COVID-19 on Middle East and Africa Market
11.2 South America Neuroscience Sales, Revenue and Market Share by Countries
11.2.1 South America Neuroscience Sales by Countries (2015-2020)
11.2.2 South America Neuroscience Revenue by Countries (2015-2020)11.3 Brazil Neuroscience Sales and Growth Rate (2015-2020)
11.4 Argentina Neuroscience Sales and Growth Rate (2015-2020)
11.5 Columbia Neuroscience Sales and Growth Rate (2015-2020)
11.6 Chile Neuroscience Sales and Growth Rate (2015-2020)
12 Competitive Landscape12.1 Lupin Ltd.
12.1.1 Lupin Ltd. Basic Information
12.1.2 Neuroscience Product Introduction
12.1.3 Lupin Ltd. Production, Value, Price, Gross Margin 2015-202012.2 Astrazeneca Plc
12.2.1 Astrazeneca Plc Basic Information
12.2.2 Neuroscience Product Introduction
12.2.3 Astrazeneca Plc Production, Value, Price, Gross Margin 2015-202012.3 Sun Pharmaceutical Industries Ltd. (Sun Pharma)
12.3.1 Sun Pharmaceutical Industries Ltd. (Sun Pharma) Basic Information
12.3.2 Neuroscience Product Introduction
12.3.3 Sun Pharmaceutical Industries Ltd. (Sun Pharma) Production, Value, Price, Gross Margin 2015-202012.4 Biogen
12.4.1 Biogen Basic Information
12.4.2 Neuroscience Product Introduction
12.4.3 Biogen Production, Value, Price, Gross Margin 2015-202012.5 UCB SA
12.5.1 UCB SA Basic Information
12.5.2 Neuroscience Product Introduction
12.5.3 UCB SA Production, Value, Price, Gross Margin 2015-202012.6 Alembic Pharmaceuticals Ltd.
12.6.1 Alembic Pharmaceuticals Ltd. Basic Information
12.6.2 Neuroscience Product Introduction
12.6.3 Alembic Pharmaceuticals Ltd. Production, Value, Price, Gross Margin 2015-2020
12.7 Torrent Pharmaceuticals Ltd.
12.7.1 Torrent Pharmaceuticals Ltd. Basic Information
12.7.2 Neuroscience Product Introduction
12.7.3 Torrent Pharmaceuticals Ltd. Production, Value, Price, Gross Margin 2015-2020
12.8 Sanofi
12.8.1 Sanofi Basic Information
12.8.2 Neuroscience Product Introduction
12.8.3 Sanofi Production, Value, Price, Gross Margin 2015-2020
12.9 Abbvie
12.9.1 Abbvie Basic Information
12.9.2 Neuroscience Product Introduction
12.9.3 Abbvie Production, Value, Price, Gross Margin 2015-202012.10 Dr. Reddy'S Laboratories Ltd.
12.10.1 Dr. Reddy'S Laboratories Ltd. Basic Information
12.10.2 Neuroscience Product Introduction
12.10.3 Dr. Reddy'S Laboratories Ltd. Production, Value, Price, Gross Margin 2015-2020
12.11 F. Hoffmann-La Roche Ag
12.11.1 F. Hoffmann-La Roche Ag Basic Information
12.11.2 Neuroscience Product Introduction
12.11.3 F. Hoffmann-La Roche Ag Production, Value, Price, Gross Margin 2015-2020
12.12 Daiichi Sankyo Co., Ltd.
12.12.1 Daiichi Sankyo Co., Ltd. Basic Information
12.12.2 Neuroscience Product Introduction
12.12.3 Daiichi Sankyo Co., Ltd. Production, Value, Price, Gross Margin 2015-2020
12.13 Avanir Pharmaceuticals Inc.
12.13.1 Avanir Pharmaceuticals Inc. Basic Information
12.13.2 Neuroscience Product Introduction
12.13.3 Avanir Pharmaceuticals Inc. Production, Value, Price, Gross Margin 2015-2020
12.14 Autism Therapeutics
12.14.1 Autism Therapeutics Basic Information
12.14.2 Neuroscience Product Introduction
12.14.3 Autism Therapeutics Production, Value, Price, Gross Margin 2015-2020
12.15 Merck & Co
12.15.1 Merck & Co Basic Information
12.15.2 Neuroscience Product Introduction
12.15.3 Merck & Co Production, Value, Price, Gross Margin 2015-2020
12.16 H. Lundbeck A/S
12.16.1 H. Lundbeck A/S Basic Information
12.16.2 Neuroscience Product Introduction
12.16.3 H. Lundbeck A/S Production, Value, Price, Gross Margin 2015-2020
12.17 Eli Lilly And Co.
12.17.1 Eli Lilly And Co. Basic Information
12.17.2 Neuroscience Product Introduction
12.17.3 Eli Lilly And Co. Production, Value, Price, Gross Margin 2015-2020
12.18 Alexza Pharmaceuticals
12.18.1 Alexza Pharmaceuticals Basic Information
12.18.2 Neuroscience Product Introduction
12.18.3 Alexza Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
12.19 United Therapeutics Corp.
12.19.1 United Therapeutics Corp. Basic Information
12.19.2 Neuroscience Product Introduction
12.19.3 United Therapeutics Corp. Production, Value, Price, Gross Margin 2015-202012.20 Allergan Plc
12.20.1 Allergan Plc Basic Information
12.20.2 Neuroscience Product Introduction
12.20.3 Allergan Plc Production, Value, Price, Gross Margin 2015-2020
12.21 Novartis Ag
12.21.1 Novartis Ag Basic Information
12.21.2 Neuroscience Product Introduction
12.21.3 Novartis Ag Production, Value, Price, Gross Margin 2015-2020
12.22 Teva Pharmaceutical Industries Ltd.
12.22.1 Teva Pharmaceutical Industries Ltd. Basic Information
12.22.2 Neuroscience Product Introduction
12.22.3 Teva Pharmaceutical Industries Ltd. Production, Value, Price, Gross Margin 2015-2020
12.23 Alkermes Plc
12.23.1 Alkermes Plc Basic Information
12.23.2 Neuroscience Product Introduction
12.23.3 Alkermes Plc Production, Value, Price, Gross Margin 2015-2020
12.24 Boehringer Ingelheim
12.24.1 Boehringer Ingelheim Basic Information
12.24.2 Neuroscience Product Introduction
12.24.3 Boehringer Ingelheim Production, Value, Price, Gross Margin 2015-2020
12.25 Pfizer Inc.
12.25.1 Pfizer Inc. Basic Information
12.25.2 Neuroscience Product Introduction
12.25.3 Pfizer Inc. Production, Value, Price, Gross Margin 2015-2020
12.26 Johnson & Johnson
12.26.1 Johnson & Johnson Basic Information
12.26.2 Neuroscience Product Introduction
12.26.3 Johnson & Johnson Production, Value, Price, Gross Margin 2015-2020
12.27 Eisai Co. Ltd.
12.27.1 Eisai Co. Ltd. Basic Information
12.27.2 Neuroscience Product Introduction
12.27.3 Eisai Co. Ltd. Production, Value, Price, Gross Margin 2015-2020
12.28 Aurobindo Pharma
12.28.1 Aurobindo Pharma Basic Information
12.28.2 Neuroscience Product Introduction
12.28.3 Aurobindo Pharma Production, Value, Price, Gross Margin 2015-2020
12.29 Sumitomo Dainippon Pharma Co., Ltd.
12.29.1 Sumitomo Dainippon Pharma Co., Ltd. Basic Information
12.29.2 Neuroscience Product Introduction
12.29.3 Sumitomo Dainippon Pharma Co., Ltd. Production, Value, Price, Gross Margin 2015-202012.30 Otsuka Holdings Co., Ltd.
12.30.1 Otsuka Holdings Co., Ltd. Basic Information
12.30.2 Neuroscience Product Introduction
12.30.3 Otsuka Holdings Co., Ltd. Production, Value, Price, Gross Margin 2015-2020
12.31 Acadia Pharmaceuticals, Inc.
12.31.1 Acadia Pharmaceuticals, Inc. Basic Information
12.31.2 Neuroscience Product Introduction
12.31.3 Acadia Pharmaceuticals, Inc. Production, Value, Price, Gross Margin 2015-2020
12.32 Gedeon Richter Plc
12.32.1 Gedeon Richter Plc Basic Information
12.32.2 Neuroscience Product Introduction
12.32.3 Gedeon Richter Plc Production, Value, Price, Gross Margin 2015-2020
12.33 Lannett Co., Inc.
12.33.1 Lannett Co., Inc. Basic Information
12.33.2 Neuroscience Product Introduction
12.33.3 Lannett Co., Inc. Production, Value, Price, Gross Margin 2015-2020
12.34 Apotex, Inc.
12.34.1 Apotex, Inc. Basic Information
12.34.2 Neuroscience Product Introduction
12.34.3 Apotex, Inc. Production, Value, Price, Gross Margin 2015-2020
12.35 Glaxosmithkline Plc
12.35.1 Glaxosmithkline Plc Basic Information
12.35.2 Neuroscience Product Introduction
12.35.3 Glaxosmithkline Plc Production, Value, Price, Gross Margin 2015-2020
12.36 Mallinckrodt
12.36.1 Mallinckrodt Basic Information
12.36.2 Neuroscience Product Introduction
12.36.3 Mallinckrodt Production, Value, Price, Gross Margin 2015-2020
12.37 Immunocellular Therapeutics, Ltd.
12.37.1 Immunocellular Therapeutics, Ltd. Basic Information
12.37.2 Neuroscience Product Introduction
12.37.3 Immunocellular Therapeutics, Ltd. Production, Value, Price, Gross Margin 2015-2020
12.38 Nextsource Biotechnology Llc
12.38.1 Nextsource Biotechnology Llc Basic Information
12.38.2 Neuroscience Product Introduction
12.38.3 Nextsource Biotechnology Llc Production, Value, Price, Gross Margin 2015-2020
12.39 Mylan Nv
12.39.1 Mylan Nv Basic Information
12.39.2 Neuroscience Product Introduction
12.39.3 Mylan Nv Production, Value, Price, Gross Margin 2015-202012.40 Bristol-Myers Squibb Co.
12.40.1 Bristol-Myers Squibb Co. Basic Information
12.40.2 Neuroscience Product Introduction
12.40.3 Bristol-Myers Squibb Co. Production, Value, Price, Gross Margin 2015-2020
13 Industry Outlook13.1 Market Driver Analysis
13.1.2 Market Restraints Analysis
13.1.3 Market Trends Analysis13.2 Merger, Acquisition and New Investment
13.3 News of Product Release
14 Global Neuroscience Market Forecast14.1 Global Neuroscience Market Value & Volume Forecast, by Type (2020-2025)
14.1.1 Anti-Parkinson's Drugs Market Value and Volume Forecast (2020-2025)
14.1.2 Alzheimer Disease Market Value and Volume Forecast (2020-2025)
14.1.3 Psychotic Disorders Market Value and Volume Forecast (2020-2025)
14.1.4 Epileptic Disorders Market Value and Volume Forecast (2020-2025)
14.1.5 Autism Spectrum Disorders Market Value and Volume Forecast (2020-2025)
14.1.6 Others Market Value and Volume Forecast (2020-2025)14.2 Global Neuroscience Market Value & Volume Forecast, by Application (2020-2025)
14.2.1 Hospitals Market Value and Volume Forecast (2020-2025)
14.2.2 Diagnostic Laboratories Market Value and Volume Forecast (2020-2025)
14.2.3 Research Institutes Market Value and Volume Forecast (2020-2025)
14.2.4 Other Market Value and Volume Forecast (2020-2025)14.3 Neuroscience Market Analysis and Forecast by Region
14.3.1 North America Market Value and Consumption Forecast (2020-2025)
14.3.2 Europe Market Value and Consumption Forecast (2020-2025)
14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)
14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)
14.3.5 South America Market Value and Consumption Forecast (2020-2025)
15 New Project Feasibility Analysis15.1 Industry Barriers and New Entrants SWOT Analysis
15.1.1 Porter’s Five Forces Analysis
15.1.2 New Entrants SWOT Analysis15.2 Analysis and Suggestions on New Project Investment
List of Tables and Figures
Figure Product Picture of Neuroscience
Table Product Specification of Neuroscience
Table Neuroscience Key Market Segments
Table Key Players Neuroscience Covered
Figure Global Neuroscience Market Size, 2015 – 2025
Table Different Types of Neuroscience
Figure Global Neuroscience Value ($) Segment by Type from 2015-2020
Figure Global Neuroscience Market Share by Types in 2019
Table Different Applications of Neuroscience
Figure Global Neuroscience Value ($) Segment by Applications from 2015-2020
Figure Global Neuroscience Market Share by Applications in 2019
Figure Global Neuroscience Market Share by Regions in 2019
Figure North America Neuroscience Production Value ($) and Growth Rate (2015-2020)
Figure Europe Neuroscience Production Value ($) and Growth Rate (2015-2020)
Figure Asia Pacific Neuroscience Production Value ($) and Growth Rate (2015-2020)
Figure Middle East and Africa Neuroscience Production Value ($) and Growth Rate (2015-2020)
Figure South America Neuroscience Production Value ($) and Growth Rate (2015-2020)
Table Global COVID-19 Status and Economic Overview
Figure Global COVID-19 Status
Figure COVID-19 Comparison of Major Countries
Figure Industry Chain Analysis of Neuroscience
Table Upstream Raw Material Suppliers of Neuroscience with Contact Information
Table Major Players Headquarters, and Service Area of Neuroscience
Figure Major Players Production Value Market Share of Neuroscience in 2019
Table Major Players Neuroscience Product Types in 2019
Figure Production Process of Neuroscience
Figure Manufacturing Cost Structure of Neuroscience
Figure Channel Status of Neuroscience
Table Major Distributors of Neuroscience with Contact Information
Table Major Downstream Buyers of Neuroscience with Contact Information
Table Global Neuroscience Value ($) by Type (2015-2020)
Table Global Neuroscience Value Share by Type (2015-2020)
Figure Global Neuroscience Value Share by Type (2015-2020)
Table Global Neuroscience Production by Type (2015-2020)
Table Global Neuroscience Production Share by Type (2015-2020)
Figure Global Neuroscience Production Share by Type (2015-2020)
Figure Global Neuroscience Value ($) and Growth Rate of Anti-Parkinson's Drugs (2015-2020)
Figure Global Neuroscience Value ($) and Growth Rate of Alzheimer Disease (2015-2020)
Figure Global Neuroscience Value ($) and Growth Rate of Psychotic Disorders (2015-2020)
Figure Global Neuroscience Value ($) and Growth Rate of Epileptic Disorders (2015-2020)
Figure Global Neuroscience Value ($) and Growth Rate of Autism Spectrum Disorders (2015-2020)
Figure Global Neuroscience Value ($) and Growth Rate of Others (2015-2020)
Figure Global Neuroscience Price by Type (2015-2020)
Figure Downstream Market Overview
Table Global Neuroscience Consumption by Application (2015-2020)
Table Global Neuroscience Consumption Market Share by Application (2015-2020)
Figure Global Neuroscience Consumption Market Share by Application (2015-2020)
Figure Global Neuroscience Consumption and Growth Rate of Hospitals (2015-2020)
Figure Global Neuroscience Consumption and Growth Rate of Diagnostic Laboratories (2015-2020)
Figure Global Neuroscience Consumption and Growth Rate of Research Institutes (2015-2020)
Figure Global Neuroscience Consumption and Growth Rate of Other (2015-2020)
Figure Global Neuroscience Sales and Growth Rate (2015-2020)
Figure Global Neuroscience Revenue (M USD) and Growth (2015-2020)
Table Global Neuroscience Sales by Regions (2015-2020)
Table Global Neuroscience Sales Market Share by Regions (2015-2020)
Table Global Neuroscience Revenue (M USD) by Regions (2015-2020)
Table Global Neuroscience Revenue Market Share by Regions (2015-2020)
Table Global Neuroscience Revenue Market Share by Regions in 2015
Table Global Neuroscience Revenue Market Share by Regions in 2019
Figure North America Neuroscience Sales and Growth Rate (2015-2020)
Figure Europe Neuroscience Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Neuroscience Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Neuroscience Sales and Growth Rate (2015-2020)
Figure South America Neuroscience Sales and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure North America COVID-19 Confirmed Cases Major Distribution
Figure North America Neuroscience Revenue (M USD) and Growth (2015-2020)
Table North America Neuroscience Sales by Countries (2015-2020)
Table North America Neuroscience Sales Market Share by Countries (2015-2020)
Table North America Neuroscience Revenue (M USD) by Countries (2015-2020)
Table North America Neuroscience Revenue Market Share by Countries (2015-2020)
Figure United States Neuroscience Sales and Growth Rate (2015-2020)
Figure Canada Neuroscience Sales and Growth Rate (2015-2020)
Figure Mexico Neuroscience Sales and Growth (2015-2020)
Figure Europe COVID-19 Status
Figure Europe COVID-19 Confirmed Cases Major Distribution
Figure Europe Neuroscience Revenue (M USD) and Growth (2015-2020)
Table Europe Neuroscience Sales by Countries (2015-2020)
Table Europe Neuroscience Sales Market Share by Countries (2015-2020)
Table Europe Neuroscience Revenue (M USD) by Countries (2015-2020)
Table Europe Neuroscience Revenue Market Share by Countries (2015-2020)
Figure Germany Neuroscience Sales and Growth Rate (2015-2020)
Figure UK Neuroscience Sales and Growth Rate (2015-2020)
Figure France Neuroscience Sales and Growth (2015-2020)
Figure Italy Neuroscience Sales and Growth (2015-2020)
Figure Spain Neuroscience Sales and Growth (2015-2020)
Figure Russia Neuroscience Sales and Growth (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Asia Pacific Neuroscience Revenue (M USD) and Growth (2015-2020)
Table Asia Pacific Neuroscience Sales by Countries (2015-2020)
Table Asia Pacific Neuroscience Sales Market Share by Countries (2015-2020)
Table Asia Pacific Neuroscience Revenue (M USD) by Countries (2015-2020)
Table Asia Pacific Neuroscience Revenue Market Share by Countries (2015-2020)
Figure China Neuroscience Sales and Growth Rate (2015-2020)
Figure Japan Neuroscience Sales and Growth Rate (2015-2020)
Figure South Korea Neuroscience Sales and Growth (2015-2020)
Figure India Neuroscience Sales and Growth (2015-2020)
Figure Southeast Asia Neuroscience Sales and Growth (2015-2020)
Figure Australia Neuroscience Sales and Growth (2015-2020)
Figure Middle East Neuroscience Revenue (M USD) and Growth (2015-2020)
Table Middle East Neuroscience Sales by Countries (2015-2020)
Table Middle East and Africa Neuroscience Sales Market Share by Countries (2015-2020)
Table Middle East and Africa Neuroscience Revenue (M USD) by Countries (2015-2020)
Table Middle East and Africa Neuroscience Revenue Market Share by Countries (2015-2020)
Figure Saudi Arabia Neuroscience Sales and Growth Rate (2015-2020)
Figure UAE Neuroscience Sales and Growth Rate (2015-2020)
Figure Egypt Neuroscience Sales and Growth (2015-2020)
Figure Nigeria Neuroscience Sales and Growth (2015-2020)
Figure South Africa Neuroscience Sales and Growth (2015-2020)
Figure South America Neuroscience Revenue (M USD) and Growth (2015-2020)
Table South America Neuroscience Sales by Countries (2015-2020)
Table South America Neuroscience Sales Market Share by Countries (2015-2020)
Table South America Neuroscience Revenue (M USD) by Countries (2015-2020)
Table South America Neuroscience Revenue Market Share by Countries (2015-2020)
Figure Brazil Neuroscience Sales and Growth Rate (2015-2020)
Figure Argentina Neuroscience Sales and Growth Rate (2015-2020)
Figure Columbia Neuroscience Sales and Growth (2015-2020)
Figure Chile Neuroscience Sales and Growth (2015-2020)
Figure Top 3 Market Share of Neuroscience Companies in 2019
Figure Top 6 Market Share of Neuroscience Companies in 2019
Table Major Players Production Value ($) Share (2015-2020)
Table Lupin Ltd. Profile
Table Lupin Ltd. Product Introduction
Figure Lupin Ltd. Production and Growth Rate
Figure Lupin Ltd. Value ($) Market Share 2015-2020
Table Astrazeneca Plc Profile
Table Astrazeneca Plc Product Introduction
Figure Astrazeneca Plc Production and Growth Rate
Figure Astrazeneca Plc Value ($) Market Share 2015-2020
Table Sun Pharmaceutical Industries Ltd. (Sun Pharma) Profile
Table Sun Pharmaceutical Industries Ltd. (Sun Pharma) Product Introduction
Figure Sun Pharmaceutical Industries Ltd. (Sun Pharma) Production and Growth Rate
Figure Sun Pharmaceutical Industries Ltd. (Sun Pharma) Value ($) Market Share 2015-2020
Table Biogen Profile
Table Biogen Product Introduction
Figure Biogen Production and Growth Rate
Figure Biogen Value ($) Market Share 2015-2020
Table UCB SA Profile
Table UCB SA Product Introduction
Figure UCB SA Production and Growth Rate
Figure UCB SA Value ($) Market Share 2015-2020
Table Alembic Pharmaceuticals Ltd. Profile
Table Alembic Pharmaceuticals Ltd. Product Introduction
Figure Alembic Pharmaceuticals Ltd. Production and Growth Rate
Figure Alembic Pharmaceuticals Ltd. Value ($) Market Share 2015-2020
Table Torrent Pharmaceuticals Ltd. Profile
Table Torrent Pharmaceuticals Ltd. Product Introduction
Figure Torrent Pharmaceuticals Ltd. Production and Growth Rate
Figure Torrent Pharmaceuticals Ltd. Value ($) Market Share 2015-2020
Table Sanofi Profile
Table Sanofi Product Introduction
Figure Sanofi Production and Growth Rate
Figure Sanofi Value ($) Market Share 2015-2020
Table Abbvie Profile
Table Abbvie Product Introduction
Figure Abbvie Production and Growth Rate
Figure Abbvie Value ($) Market Share 2015-2020
Table Dr. Reddy'S Laboratories Ltd. Profile
Table Dr. Reddy'S Laboratories Ltd. Product Introduction
Figure Dr. Reddy'S Laboratories Ltd. Production and Growth Rate
Figure Dr. Reddy'S Laboratories Ltd. Value ($) Market Share 2015-2020
Table F. Hoffmann-La Roche Ag Profile
Table F. Hoffmann-La Roche Ag Product Introduction
Figure F. Hoffmann-La Roche Ag Production and Growth Rate
Figure F. Hoffmann-La Roche Ag Value ($) Market Share 2015-2020
Table Daiichi Sankyo Co., Ltd. Profile
Table Daiichi Sankyo Co., Ltd. Product Introduction
Figure Daiichi Sankyo Co., Ltd. Production and Growth Rate
Figure Daiichi Sankyo Co., Ltd. Value ($) Market Share 2015-2020
Table Avanir Pharmaceuticals Inc. Profile
Table Avanir Pharmaceuticals Inc. Product Introduction
Figure Avanir Pharmaceuticals Inc. Production and Growth Rate
Figure Avanir Pharmaceuticals Inc. Value ($) Market Share 2015-2020
Table Autism Therapeutics Profile
Table Autism Therapeutics Product Introduction
Figure Autism Therapeutics Production and Growth Rate
Figure Autism Therapeutics Value ($) Market Share 2015-2020
Table Merck & Co Profile
Table Merck & Co Product Introduction
Figure Merck & Co Production and Growth Rate
Figure Merck & Co Value ($) Market Share 2015-2020
Table H. Lundbeck A/S Profile
Table H. Lundbeck A/S Product Introduction
Figure H. Lundbeck A/S Production and Growth Rate
Figure H. Lundbeck A/S Value ($) Market Share 2015-2020
Table Eli Lilly And Co. Profile
Table Eli Lilly And Co. Product Introduction
Figure Eli Lilly And Co. Production and Growth Rate
Figure Eli Lilly And Co. Value ($) Market Share 2015-2020
Table Alexza Pharmaceuticals Profile
Table Alexza Pharmaceuticals Product Introduction
Figure Alexza Pharmaceuticals Production and Growth Rate
Figure Alexza Pharmaceuticals Value ($) Market Share 2015-2020
Table United Therapeutics Corp. Profile
Table United Therapeutics Corp. Product Introduction
Figure United Therapeutics Corp. Production and Growth Rate
Figure United Therapeutics Corp. Value ($) Market Share 2015-2020
Table Allergan Plc Profile
Table Allergan Plc Product Introduction
Figure Allergan Plc Production and Growth Rate
Figure Allergan Plc Value ($) Market Share 2015-2020
Table Novartis Ag Profile
Table Novartis Ag Product Introduction
Figure Novartis Ag Production and Growth Rate
Figure Novartis Ag Value ($) Market Share 2015-2020
Table Teva Pharmaceutical Industries Ltd. Profile
Table Teva Pharmaceutical Industries Ltd. Product Introduction
Figure Teva Pharmaceutical Industries Ltd. Production and Growth Rate
Figure Teva Pharmaceutical Industries Ltd. Value ($) Market Share 2015-2020
Table Alkermes Plc Profile
Table Alkermes Plc Product Introduction
Figure Alkermes Plc Production and Growth Rate
Figure Alkermes Plc Value ($) Market Share 2015-2020
Table Boehringer Ingelheim Profile
Table Boehringer Ingelheim Product Introduction
Figure Boehringer Ingelheim Production and Growth Rate
Figure Boehringer Ingelheim Value ($) Market Share 2015-2020
Table Pfizer Inc. Profile
Table Pfizer Inc. Product Introduction
Figure Pfizer Inc. Production and Growth Rate
Figure Pfizer Inc. Value ($) Market Share 2015-2020
Table Johnson & Johnson Profile
Table Johnson & Johnson Product Introduction
Figure Johnson & Johnson Production and Growth Rate
Figure Johnson & Johnson Value ($) Market Share 2015-2020
Table Eisai Co. Ltd. Profile
Table Eisai Co. Ltd. Product Introduction
Figure Eisai Co. Ltd. Production and Growth Rate
Figure Eisai Co. Ltd. Value ($) Market Share 2015-2020
Table Aurobindo Pharma Profile
Table Aurobindo Pharma Product Introduction
Figure Aurobindo Pharma Production and Growth Rate
Figure Aurobindo Pharma Value ($) Market Share 2015-2020
Table Sumitomo Dainippon Pharma Co., Ltd. Profile
Table Sumitomo Dainippon Pharma Co., Ltd. Product Introduction
Figure Sumitomo Dainippon Pharma Co., Ltd. Production and Growth Rate
Figure Sumitomo Dainippon Pharma Co., Ltd. Value ($) Market Share 2015-2020
Table Otsuka Holdings Co., Ltd. Profile
Table Otsuka Holdings Co., Ltd. Product Introduction
Figure Otsuka Holdings Co., Ltd. Production and Growth Rate
Figure Otsuka Holdings Co., Ltd. Value ($) Market Share 2015-2020
Table Acadia Pharmaceuticals, Inc. Profile
Table Acadia Pharmaceuticals, Inc. Product Introduction
Figure Acadia Pharmaceuticals, Inc. Production and Growth Rate
Figure Acadia Pharmaceuticals, Inc. Value ($) Market Share 2015-2020
Table Gedeon Richter Plc Profile
Table Gedeon Richter Plc Product Introduction
Figure Gedeon Richter Plc Production and Growth Rate
Figure Gedeon Richter Plc Value ($) Market Share 2015-2020
Table Lannett Co., Inc. Profile
Table Lannett Co., Inc. Product Introduction
Figure Lannett Co., Inc. Production and Growth Rate
Figure Lannett Co., Inc. Value ($) Market Share 2015-2020
Table Apotex, Inc. Profile
Table Apotex, Inc. Product Introduction
Figure Apotex, Inc. Production and Growth Rate
Figure Apotex, Inc. Value ($) Market Share 2015-2020
Table Glaxosmithkline Plc Profile
Table Glaxosmithkline Plc Product Introduction
Figure Glaxosmithkline Plc Production and Growth Rate
Figure Glaxosmithkline Plc Value ($) Market Share 2015-2020
Table Mallinckrodt Profile
Table Mallinckrodt Product Introduction
Figure Mallinckrodt Production and Growth Rate
Figure Mallinckrodt Value ($) Market Share 2015-2020
Table Immunocellular Therapeutics, Ltd. Profile
Table Immunocellular Therapeutics, Ltd. Product Introduction
Figure Immunocellular Therapeutics, Ltd. Production and Growth Rate
Figure Immunocellular Therapeutics, Ltd. Value ($) Market Share 2015-2020
Table Nextsource Biotechnology Llc Profile
Table Nextsource Biotechnology Llc Product Introduction
Figure Nextsource Biotechnology Llc Production and Growth Rate
Figure Nextsource Biotechnology Llc Value ($) Market Share 2015-2020
Table Mylan Nv Profile
Table Mylan Nv Product Introduction
Figure Mylan Nv Production and Growth Rate
Figure Mylan Nv Value ($) Market Share 2015-2020
Table Bristol-Myers Squibb Co. Profile
Table Bristol-Myers Squibb Co. Product Introduction
Figure Bristol-Myers Squibb Co. Production and Growth Rate
Figure Bristol-Myers Squibb Co. Value ($) Market Share 2015-2020
Table Market Driving Factors of Neuroscience
Table Merger, Acquisition and New Investment
Table Global Neuroscience Market Value ($) Forecast, by Type
Table Global Neuroscience Market Volume Forecast, by Type
Figure Global Neuroscience Market Value ($) and Growth Rate Forecast of Anti-Parkinson's Drugs (2020-2025)
Figure Global Neuroscience Market Volume ($) and Growth Rate Forecast of Anti-Parkinson's Drugs (2020-2025)
Figure Global Neuroscience Market Value ($) and Growth Rate Forecast of Alzheimer Disease (2020-2025)
Figure Global Neuroscience Market Volume ($) and Growth Rate Forecast of Alzheimer Disease (2020-2025)
Figure Global Neuroscience Market Value ($) and Growth Rate Forecast of Psychotic Disorders (2020-2025)
Figure Global Neuroscience Market Volume ($) and Growth Rate Forecast of Psychotic Disorders (2020-2025)
Figure Global Neuroscience Market Value ($) and Growth Rate Forecast of Epileptic Disorders (2020-2025)
Figure Global Neuroscience Market Volume ($) and Growth Rate Forecast of Epileptic Disorders (2020-2025)
Figure Global Neuroscience Market Value ($) and Growth Rate Forecast of Autism Spectrum Disorders (2020-2025)
Figure Global Neuroscience Market Volume ($) and Growth Rate Forecast of Autism Spectrum Disorders (2020-2025)
Figure Global Neuroscie
-
The COVID 19 Outbreak Global Neuroscience Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
Recognize the areas along the COVID 19 Outbreak Global Neuroscience Market's value chain where players are generating value. To get a complete picture, kindly read the entire report.
COVID 19 Outbreak Global Neuroscience has a wide range of applications, including
From 2024 to 2029, the COVID 19 Outbreak Global Neuroscience Market is expected to grow at a compound annual growth rate of YY%, reaching a value of USD XXX Million.
As the shift to value addition continues, companies in the COVID 19 Outbreak Global Neuroscience Market face the dual challenge of improving interoperability to optimize performance and experience.
The COVID 19 Outbreak Global Neuroscience Industry stakeholders, executives, and experts, as well as individuals who need to develop consumer-friendly strategies and use technology to stay ahead of the competition.
